Table 2 Number (%) of patients and number (%) of deaths considering comorbidities in hospitalized Iranian COVID-19 patients divided by age groups
Co-morbidity | Under 1 (1239) | 1-5 years (2252) | 6-12 years (1617) | 13-17 years (1502) | Total (6610) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Number | Deaths | Number | Death | Number | Death | Number | Death | Number | Death | |
Cardiovascular diseases | ||||||||||
 Yes | 55 (4.4%) | 9 (16.4%) | 57 (2.5%) | 9 (15.8%) | 32 (2.0%) | 6 (18.7%) | 39 (2.6%) | 7 (17.9%) | 183 (2.8%) | 31 (16.9%) |
 No | 1184 (95.6%) | 76 (6.4%) | 2195 (97.5%) | 86 (3.9%) | 1585 (98.0%) | 70 (4.4%) | 1463 (97.4%) | 89 (6.0%) | 6427 (97.2%) | 321 (5.0%) |
Diabetes | ||||||||||
 Yes | 20 (1.6%) | 6 (30.0%) | 32 (1.4%) | 4 (12.5%) | 27 (1.7%) | 4 (14.8%) | 28 (1.9%) | 2 (7.1%) | 107 (1.6%) | 16 (14.9%) |
 No | 1219 (98.4%) | 79 (6.5%) | 2220 (98.6%) | 91 (4.1%) | 1590 (98.3%) | 72 (4.5%) | 1474 (98.1%) | 94 (6.4%) | 6503 (98.4%) | 336 (5.2%) |
Chronic pulmonary diseasesa | ||||||||||
 Yes | 5 (0.5%) | 1 (20.0%) | 27 (1.3%) | 5 (18.5%) | 18 (1.2%) | 0 (0.0%) | 16 (1.1%) | 5 (31.2%) | 66 (1.1%) | 11 (16.7%) |
 No | 1006 (99.5%) | 63 (6.3%) | 2072 (98.7%) | 79 (3.8%) | 1531 (98.8%) | 68 (4.4%) | 1403 (98.9%) | 82 (5.8%) | 6012 (98.9%) | 292 (4.9%) |
Liver dysfunction | ||||||||||
 Yes | 2 (0.2%) | 0 (0.0%) | 14 (0.6%) | 3 (21.4%) | 11 (0.7%) | 2 (18.2%) | 5 (0.3%) | 1 (20.0%) | 32 (0.5%) | 6 (18.8%) |
 No | 1237 (99.8%) | 85 (6.9%) | 2238 (99.4%) | 92 (4.1%) | 1606 (99.3%) | 74 (4.6%) | 1497 (99.7%) | 95 (6.3%) | 6578 (99.5%) | 346 (5.3%) |
Kidney dysfunction | ||||||||||
 Yes | 6 (0.5%) | 2 (33.4%) | 9 (0.4%) | 1 (11.2%) | 20 (1.2%) | 5 (25.0%) | 30 (2.0%) | 5 (16.7%) | 65 (1.0%) | 13 (20.0%) |
 No | 1233 (99.5%) | 83 (6.7%) | 2243 (99.6%) | 94 (4.2%) | 1597 (98.8%) | 71 (4.4%) | 1472 (98.0%) | 91 (6.2%) | 6545 (99.0%) | 339 (5.2%) |
Malignancies | ||||||||||
 Yes | 1(< 0.1%) | 1 (100.0%) | 19 (0.8%) | 1 (5.3%) | 41 (2.5%) | 6 (14.6%) | 37 (2.5%) | 3 (8.1%) | 98 (1.5%) | 11 (11.2%) |
 No | 1238 (> 99.9%) | 84 (6.8%) | 2233 (99.2%) | 94 (4.2%) | 1576 (97.5%) | 70 (4.4%) | 1465 (97.5%) | 93 (6.3%) | 6512 (98.5%) | 341 (5.2%) |
Immunodeficiency disorders | ||||||||||
 Yes | 2 (0.2%) | 0 (0.0%) | 9 (0.4%) | 0 (0.0%) | 15 (0.9%) | 1 (6.7%) | 13 (0.9%) | 2 (15.4%) | 39 (0.6%) | 3 (7.7%) |
 No | 1237 (99.8%) | 85 (6.9%) | 2243 (99.6%) | 95 (4.2%) | 1602 (99.1%) | 75 (4.7%) | 1489 (99.1%) | 94 (6.3%) | 6571 (99.4%) | 349 (5.3%) |